{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:33:59Z","timestamp":1791182039606,"version":"4.1.0"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2012,6,20]],"date-time":"2012-06-20T00:00:00Z","timestamp":1340150400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0039468","type":"journal-article","created":{"date-parts":[[2012,6,21]],"date-time":"2012-06-21T12:12:01Z","timestamp":1340280721000},"page":"e39468","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":68,"title":["Evidence for Cognitive Impairment in Mastocytosis: Prevalence, Features and Correlations to Depression"],"prefix":"10.1371","volume":"7","author":[{"given":"Daniela Silva","family":"Moura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Georgin-Lavialle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Barete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,6,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2559.1979.tb03017.x","article-title":"Mast cells and mast cell neoplasia: a review.","volume":"3","author":"K Lennert","year":"1979","journal-title":"Histopathology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1111\/1523-1747.ep12468882","article-title":"Classification and diagnosis of mastocytosis: current status.","volume":"96","author":"DD Metcalfe","year":"1991","journal-title":"J Invest Dermatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal.","volume":"25","author":"P Valent","year":"2001","journal-title":"Leuk Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0889-8588(03)00089-3","article-title":"Mast cell proliferative disorders: current view on variants recognized by the World Health Organization.","volume":"17","author":"P Valent","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e1906","DOI":"10.1371\/journal.pone.0001906","article-title":"Phenotypic and genotypic characteristics of mastocytosis according to the age of onset.","volume":"3","author":"F Lanternier","year":"2008","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e2266","DOI":"10.1371\/journal.pone.0002266","article-title":"Case-control cohort study of patients&apos; perceptions of disability in mastocytosis.","volume":"3","author":"O Hermine","year":"2008","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00006842-198607000-00006","article-title":"Mixed organic brain syndrome as a manifestation of systemic mastocytosis.","volume":"48","author":"MP Rogers","year":"1986","journal-title":"Psychosom Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e26375","DOI":"10.1371\/journal.pone.0026375","article-title":"Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy.","volume":"6","author":"DS Moura","year":"2011","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3233\/JAD-2009-1120","article-title":"A systematic review of neuropsychiatric symptoms in mild cognitive impairment.","volume":"18","author":"MF Monastero R","year":"2009","journal-title":"Journal of Alzheimer's disease"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpsychires.2003.08.002","article-title":"Verbal memory performance of patients with a first depressive episode and patients with unipolar and bipolar recurrent depression.","volume":"38","author":"HP Fossati P","year":"2004","journal-title":"Journal of psychiatric research"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2011.06.014","article-title":"Psychosocial and neurocognitive profiles in depressed patients with major depressive disorder and bipolar disorder.","author":"GS Godard J","year":"2011"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1037\/a0017336","article-title":"Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis.","volume":"24","author":"HM McClintock SM","year":"2010","journal-title":"Neuropsychology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2007.06.006","article-title":"A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults.","volume":"106","author":"T-HA Castaneda AE","year":"2008","journal-title":"journal of Affective disorders"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"328602","DOI":"10.1155\/2011\/328602","article-title":"Histaminergic mechanisms for modulation of memory systems.","volume":"2011","author":"CA Kohler","year":"2011","journal-title":"Neural Plast"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1017\/S1041610294001663","article-title":"Estimated prevalence of age-associated memory impairment derived from standardized tests of memory function.","volume":"6","author":"CTr Larrabee GJ","year":"1994","journal-title":"International psychogeriatrics"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1474-4422(03)00262-X","article-title":"Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment.","volume":"2","author":"C DeCarli","year":"2003","journal-title":"The Lancet Neurology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1471-2377-11-147","article-title":"Prevalence of cognitive impairment in individuals aged over 65 in an urban area: DERIVA study.","volume":"11","author":"E Rodriguez-Sanchez","year":"2011","journal-title":"BMC Neurol"},{"key":"ref18","article-title":"Metabolic Syndrome, Diabetes, Poor Cognition, and Dementia in the Caerphilly Prospective Study.","author":"ST Creavin","year":"2011"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jalz.2011.02.008","article-title":"Cognitive impairment in nondemented oldest-old: prevalence and relationship to cardiovascular risk factors.","volume":"8","author":"CB Peltz","year":"2012","journal-title":"Alzheimers Dement"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/archneurol.2011.82","article-title":"Mild cognitive impairment, dementia, and their subtypes in oldest old women.","volume":"68","author":"K Yaffe","year":"2011","journal-title":"Arch Neurol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1080\/13803395.2011.603690","article-title":"Epidemiological characteristics of cognitive impairment of multiple sclerosis patients in a Latin American country.","volume":"33","author":"F Caceres","year":"2011","journal-title":"J Clin Exp Neuropsychol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00019052-200306000-00006","article-title":"Cognitive dysfunction in multiple sclerosis: a review of recent developments.","volume":"16","author":"JA Bobholz","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1212\/WNL.41.5.685","article-title":"Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction.","volume":"41","author":"SM Rao","year":"1991","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.biopsych.2009.03.015","article-title":"Inflammation Causes Mood Changes Through Alterations in Subgenual Cingulate Activity and Mesolimbic Connectivity.","volume":"66","author":"NA Harrison","year":"2009","journal-title":"Biological Psychiatry"},{"key":"ref25","first-page":"446","article-title":"A Meta-Analysis of Cytokines in Major Depression Biological Psychiatry","volume":"67","author":"Y Dowlati","year":"2010"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/npp.2011.205","article-title":"Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior.","volume":"37","author":"E Haroon","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1523\/JNEUROSCI.23-10-03999.2003","article-title":"Functional-anatomic correlates of control processes in memory.","volume":"15","author":"RL Buckner","year":"2003","journal-title":"The journal of neuroscience"},{"key":"ref28","article-title":"GnRH, brain mast cells and behavior. Progress in Brain Research: Elsevier.","author":"A-J Silverman","year":"2002"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1073\/pnas.91.9.3695","article-title":"Mast cells with gonadotropin-releasing hormone-like immunoreactivity in the brain of doves.","volume":"91","author":"AJ Silverman","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ygcen.2011.03.018","article-title":"Neuro-immune interactions in the dove brain.","volume":"172","author":"M Wilhelm","year":"2010","journal-title":"General and Comparative Endocrinology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1210\/endo.138.12.5592","article-title":"Lescheid DW, Terasawa E, Abler LA, Urbanski HF, Warby CM, et al. (1997 ) A second form of gonadotropin-releasing hormone (GnRH) with characteristics of chicken GnRH-II is present in the primate brain.","volume":"138","journal-title":"Endocrinology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.psyneuen.2009.12.012","article-title":"The interactive effect of acute ovarian suppression and the cholinergic system on visuospatial working memory in young women.","volume":"35","author":"MC Craig","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/0306-4522(95)00606-0","article-title":"Definitive characterization of rat hypothalamic mast cells.","volume":"73","author":"X Pang","year":"1996","journal-title":"Neuroscience"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/nimg.2002.1087","article-title":"Functional Neuroanatomy of Emotion: A Meta-Analysis of Emotion Activation Studies in PET and fMRI.","volume":"16","author":"KL Phan","year":"2002","journal-title":"NeuroImage"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"14293","DOI":"10.1523\/JNEUROSCI.3301-08.2008","article-title":"Memory enhancement with event-related stimulation of the rostral intralaminar thalamic nuclei.","volume":"28","author":"RG Mair","year":"2008","journal-title":"J Neurosci"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"18053","DOI":"10.1073\/pnas.0809479105","article-title":"Brain mast cells link the immune system to anxiety-like behavior.","volume":"105","author":"KM Nautiyal","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/JCP.0b013e3181845f48","article-title":"Autism, gut-blood-brain barrier, and mast cells.","volume":"28","author":"TC Theoharides","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2010.12.017","article-title":"Mast cell activation and autism.","author":"TC Theoharides","year":"2012"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/039463200902200401","article-title":"Autism spectrum disorders and mastocytosis.","volume":"22","author":"T Theoharides","year":"2009","journal-title":"Int J Immunopathol Pharmaco"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.194.1.71","article-title":"Brain mast cells act as an immune gate to the hypothalamic-pituitary-adrenal axis in dogs.","volume":"194","author":"I Matsumoto","year":"2001","journal-title":"J Exp Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0006-8993(00)03026-2","article-title":"Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells.","volume":"888","author":"P Esposito","year":"2001","journal-title":"Brain Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.1210\/endo.136.12.7588332","article-title":"Stress-induced intracranial mast cell degranulation: a corticotropin-releasing hormone-mediated effect.","volume":"136","author":"TC Theoharides","year":"1995","journal-title":"Endocrinology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1210\/endo.139.1.5660","article-title":"Corticotropin-Releasing Hormone Induces Skin Mast Cell Degranulation and Increased Vascular Permeability, A Possible Explanation for Its Proinflammatory Effects.","volume":"139","author":"TC Theoharides","year":"1998","journal-title":"Endocrinology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4530(01)00071-3","article-title":"Cognitive impairment correlates with hypothalamo-pituitary-adrenal axis dysregulation in multiple sclerosis.","volume":"27","author":"C Heesen","year":"2002","journal-title":"Psychoneuroendocrinology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"14436","DOI":"10.1523\/JNEUROSCI.3836-11.2011","article-title":"Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy.","volume":"31","author":"JC Carroll","year":"2011","journal-title":"J Neurosci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1210\/jc.2006-2540","article-title":"Hypothalamic-pituitary-adrenal axis dysregulation and memory impairments in type 2 diabetes.","volume":"92","author":"H Bruehl","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/alzrt75","article-title":"Masitinib as an adjunct therapy for mild-to-moderate Alzheimer&apos;s disease: a randomised, placebo-controlled phase 2 trial.","volume":"3","author":"F Piette","year":"2011","journal-title":"Alzheimers Res Ther"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ajh.21894","article-title":"Paul C, Sans B, Suarez F, Casassus P, Barete S, et al. (2010 ) Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: a phase 2a study.","volume":"85","journal-title":"Am J Hematol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3233\/JAD-2011-110131","article-title":"Targeting the kynurenine pathway-related alterations in Alzheimer&apos;s disease: a future therapeutic strategy.","volume":"24","author":"I Plangar","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","article-title":"Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration.","volume":"145","author":"D Zwilling","year":"2011","journal-title":"Cell"},{"key":"ref51","article-title":"Wechsler Memory Scale,Revised.","author":"D Wechsler","year":"1987"},{"key":"ref52","first-page":"56","article-title":"A rating scale for depression J Neurol Neurosurg Psychiatry","volume":"23","author":"M Hamilton","year":"1960"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0039468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:39:44Z","timestamp":1589038784000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0039468"}},"subtitle":[],"editor":[{"given":"Kenji","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,6,20]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,6,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0039468","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,20]]}}}